Waverley Pharma Inc

$180,000.00 CAD

≈ 2 Canadians' average pay for a year

Department: National Research Council Canada
Program: Industrial Research Assistance Program – Contributions to Firms
Recipient country: Canada
Fiscal year: 2018-2019
Agreement period: April 2, 2018 – February 28, 2021
Reference: nrc-cnrc:172-2018-2019-Q1-901202

Published purpose

The aim of the project is to develop and commercialize pharmaceutical drugs for the treatment of cancer. The Company's current focus is on the generic oncology generic injectible market in the European Union and North America. Currently, Waverley Pharma Inc. has two products WAV-101 and WAV-102 for the treatment of cancer.

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful

View official source record Imported August 3, 2026 from open.canada.ca Grants & Contributions